Liza Amlani (29:16) I think we can talk about this for hours
The plotter is a planning tool, not a safety net
efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials
& Nikam, T
Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C: Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial
These measurements inform realistic expectations about cholesterol improvements and determine whether additional lipid-lowering medications remain necessary during treatment